This inventor holds 1 USPTO granted patent. Top assignees: Colibri Photonics Gmbh, Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 4,920 
1 out of 911 
Years Active: 2017
Title: Sebastian Prill: Innovator in Toxicity Monitoring
Introduction
Sebastian Prill is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of physiological monitoring, particularly in the area of toxicity assessment. His innovative approach has the potential to enhance the understanding of cellular health and environmental interactions.
Latest Patents
Sebastian Prill holds a patent for a "Method and system for continuous monitoring of toxicity." This patent encompasses systems, kits, and methods for non-invasive, long-term, real-time monitoring of one or more physiological parameters of a cell, including but not limited to oxygen uptake. This invention represents a significant advancement in the ability to monitor cellular conditions effectively.
Career Highlights
Throughout his career, Sebastian has worked with various esteemed organizations. Notably, he has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Colibri Photonics GmbH. His work in these companies has allowed him to collaborate with leading experts in the field.
Collaborations
Sebastian has collaborated with talented individuals such as Elmar Schmälzlin and Danny Bavli. These partnerships have contributed to the development and refinement of his innovative ideas.
Conclusion
Sebastian Prill's work in toxicity monitoring exemplifies the impact of innovation in the field of physiological research. His contributions are paving the way for advancements that could significantly improve health monitoring practices.